 | • レポートコード：MRC2-11QY07315 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肝硬変治療薬のグローバル市場について調査・分析したレポートです。種類別（経口、注射）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肝硬変治療薬の競争状況、市場シェア ・世界の肝硬変治療薬市場：種類別市場規模 2015年-2020年（経口、注射） ・世界の肝硬変治療薬市場：種類別市場規模予測 2021年-2026年（経口、注射） ・世界の肝硬変治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の肝硬変治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の肝硬変治療薬市場分析：米国、カナダ ・ヨーロッパの肝硬変治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肝硬変治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肝硬変治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肝硬変治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Gilead Sciences、GlaxoSmithKline、Johnson and Johnson、Merck、Roche、Bristol-Myers Squibb、Conatus Pharmaceuticals、Gwo Xi Stem Cell Applied Technology、Instituto Grifols、Intercept Pharmaceuticals、NGM Biopharmaceuticals、Norgine、Pharmicell、Salix Pharmaceuticals、Stempeutics Research ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Liver Cirrhosis Therapeutics Market
The global Liver Cirrhosis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Liver Cirrhosis Therapeutics Scope and Market Size
Liver Cirrhosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liver Cirrhosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Liver Cirrhosis Therapeutics market is segmented into
Oral
Injection
Segment by Application, the Liver Cirrhosis Therapeutics market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Liver Cirrhosis Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Liver Cirrhosis Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Liver Cirrhosis Therapeutics Market Share Analysis
Liver Cirrhosis Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liver Cirrhosis Therapeutics business, the date to enter into the Liver Cirrhosis Therapeutics market, Liver Cirrhosis Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Gilead Sciences
GlaxoSmithKline
Johnson and Johnson
Merck
Roche
Bristol-Myers Squibb
Conatus Pharmaceuticals
Gwo Xi Stem Cell Applied Technology
Instituto Grifols
Intercept Pharmaceuticals
NGM Biopharmaceuticals
Norgine
Pharmicell
Salix Pharmaceuticals
Stempeutics Research
1 Study Coverage
1.1 Liver Cirrhosis Therapeutics Product Introduction
1.2 Market Segments
1.3 Key Liver Cirrhosis Therapeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Liver Cirrhosis Therapeutics Market Size, Estimates and Forecasts
2.1.1 Global Liver Cirrhosis Therapeutics Revenue 2015-2026
2.1.2 Global Liver Cirrhosis Therapeutics Sales 2015-2026
2.2 Global Liver Cirrhosis Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Liver Cirrhosis Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Liver Cirrhosis Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Liver Cirrhosis Therapeutics Competitor Landscape by Players
3.1 Liver Cirrhosis Therapeutics Sales by Manufacturers
3.1.1 Liver Cirrhosis Therapeutics Sales by Manufacturers (2015-2020)
3.1.2 Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Liver Cirrhosis Therapeutics Revenue by Manufacturers
3.2.1 Liver Cirrhosis Therapeutics Revenue by Manufacturers (2015-2020)
3.2.2 Liver Cirrhosis Therapeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liver Cirrhosis Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Liver Cirrhosis Therapeutics Revenue in 2019
3.2.5 Global Liver Cirrhosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Liver Cirrhosis Therapeutics Price by Manufacturers
3.4 Liver Cirrhosis Therapeutics Manufacturing Base Distribution, Product Types
3.4.1 Liver Cirrhosis Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liver Cirrhosis Therapeutics Product Type
3.4.3 Date of International Manufacturers Enter into Liver Cirrhosis Therapeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Liver Cirrhosis Therapeutics Market Size by Type (2015-2020)
4.1.1 Global Liver Cirrhosis Therapeutics Sales by Type (2015-2020)
4.1.2 Global Liver Cirrhosis Therapeutics Revenue by Type (2015-2020)
4.1.3 Liver Cirrhosis Therapeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Liver Cirrhosis Therapeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Liver Cirrhosis Therapeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Liver Cirrhosis Therapeutics Revenue Forecast by Type (2021-2026)
4.2.3 Liver Cirrhosis Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Liver Cirrhosis Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Liver Cirrhosis Therapeutics Market Size by Application (2015-2020)
5.1.1 Global Liver Cirrhosis Therapeutics Sales by Application (2015-2020)
5.1.2 Global Liver Cirrhosis Therapeutics Revenue by Application (2015-2020)
5.1.3 Liver Cirrhosis Therapeutics Price by Application (2015-2020)
5.2 Liver Cirrhosis Therapeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Liver Cirrhosis Therapeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Liver Cirrhosis Therapeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Liver Cirrhosis Therapeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Liver Cirrhosis Therapeutics by Country
6.1.1 North America Liver Cirrhosis Therapeutics Sales by Country
6.1.2 North America Liver Cirrhosis Therapeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Liver Cirrhosis Therapeutics Market Facts & Figures by Type
6.3 North America Liver Cirrhosis Therapeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Liver Cirrhosis Therapeutics by Country
7.1.1 Europe Liver Cirrhosis Therapeutics Sales by Country
7.1.2 Europe Liver Cirrhosis Therapeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liver Cirrhosis Therapeutics Market Facts & Figures by Type
7.3 Europe Liver Cirrhosis Therapeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Liver Cirrhosis Therapeutics by Region
8.1.1 Asia Pacific Liver Cirrhosis Therapeutics Sales by Region
8.1.2 Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Liver Cirrhosis Therapeutics Market Facts & Figures by Type
8.3 Asia Pacific Liver Cirrhosis Therapeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Liver Cirrhosis Therapeutics by Country
9.1.1 Latin America Liver Cirrhosis Therapeutics Sales by Country
9.1.2 Latin America Liver Cirrhosis Therapeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Liver Cirrhosis Therapeutics Market Facts & Figures by Type
9.3 Central & South America Liver Cirrhosis Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Liver Cirrhosis Therapeutics by Country
10.1.1 Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country
10.1.2 Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Liver Cirrhosis Therapeutics Market Facts & Figures by Type
10.3 Middle East and Africa Liver Cirrhosis Therapeutics Market Facts & Figures by Application
11 Company Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Description and Business Overview
11.1.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Products Offered
11.1.5 Gilead Sciences Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Johnson and Johnson
11.3.1 Johnson and Johnson Corporation Information
11.3.2 Johnson and Johnson Description and Business Overview
11.3.3 Johnson and Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson and Johnson Liver Cirrhosis Therapeutics Products Offered
11.3.5 Johnson and Johnson Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Liver Cirrhosis Therapeutics Products Offered
11.4.5 Merck Related Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Description and Business Overview
11.5.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Roche Liver Cirrhosis Therapeutics Products Offered
11.5.5 Roche Related Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Description and Business Overview
11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Products Offered
11.6.5 Bristol-Myers Squibb Related Developments
11.7 Conatus Pharmaceuticals
11.7.1 Conatus Pharmaceuticals Corporation Information
11.7.2 Conatus Pharmaceuticals Description and Business Overview
11.7.3 Conatus Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Products Offered
11.7.5 Conatus Pharmaceuticals Related Developments
11.8 Gwo Xi Stem Cell Applied Technology
11.8.1 Gwo Xi Stem Cell Applied Technology Corporation Information
11.8.2 Gwo Xi Stem Cell Applied Technology Description and Business Overview
11.8.3 Gwo Xi Stem Cell Applied Technology Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Products Offered
11.8.5 Gwo Xi Stem Cell Applied Technology Related Developments
11.9 Instituto Grifols
11.9.1 Instituto Grifols Corporation Information
11.9.2 Instituto Grifols Description and Business Overview
11.9.3 Instituto Grifols Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Products Offered
11.9.5 Instituto Grifols Related Developments
11.10 Intercept Pharmaceuticals
11.10.1 Intercept Pharmaceuticals Corporation Information
11.10.2 Intercept Pharmaceuticals Description and Business Overview
11.10.3 Intercept Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Products Offered
11.10.5 Intercept Pharmaceuticals Related Developments
11.1 Gilead Sciences
11.1.1 Gilead Sciences Corporation Information
11.1.2 Gilead Sciences Description and Business Overview
11.1.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Products Offered
11.1.5 Gilead Sciences Related Developments
11.12 Norgine
11.12.1 Norgine Corporation Information
11.12.2 Norgine Description and Business Overview
11.12.3 Norgine Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Norgine Products Offered
11.12.5 Norgine Related Developments
11.13 Pharmicell
11.13.1 Pharmicell Corporation Information
11.13.2 Pharmicell Description and Business Overview
11.13.3 Pharmicell Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pharmicell Products Offered
11.13.5 Pharmicell Related Developments
11.14 Salix Pharmaceuticals
11.14.1 Salix Pharmaceuticals Corporation Information
11.14.2 Salix Pharmaceuticals Description and Business Overview
11.14.3 Salix Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Salix Pharmaceuticals Products Offered
11.14.5 Salix Pharmaceuticals Related Developments
11.15 Stempeutics Research
11.15.1 Stempeutics Research Corporation Information
11.15.2 Stempeutics Research Description and Business Overview
11.15.3 Stempeutics Research Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Stempeutics Research Products Offered
11.15.5 Stempeutics Research Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Liver Cirrhosis Therapeutics Market Estimates and Projections by Region
12.1.1 Global Liver Cirrhosis Therapeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Liver Cirrhosis Therapeutics Revenue Forecast by Regions 2021-2026
12.2 North America Liver Cirrhosis Therapeutics Market Size Forecast (2021-2026)
12.2.1 North America: Liver Cirrhosis Therapeutics Sales Forecast (2021-2026)
12.2.2 North America: Liver Cirrhosis Therapeutics Revenue Forecast (2021-2026)
12.2.3 North America: Liver Cirrhosis Therapeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Liver Cirrhosis Therapeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Liver Cirrhosis Therapeutics Sales Forecast (2021-2026)
12.3.2 Europe: Liver Cirrhosis Therapeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Liver Cirrhosis Therapeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Liver Cirrhosis Therapeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Liver Cirrhosis Therapeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Liver Cirrhosis Therapeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Liver Cirrhosis Therapeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Liver Cirrhosis Therapeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Liver Cirrhosis Therapeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Liver Cirrhosis Therapeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Liver Cirrhosis Therapeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Liver Cirrhosis Therapeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Liver Cirrhosis Therapeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Liver Cirrhosis Therapeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Liver Cirrhosis Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Liver Cirrhosis Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liver Cirrhosis Therapeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Liver Cirrhosis Therapeutics Market Segments
Table 2. Ranking of Global Top Liver Cirrhosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injection
Table 6. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Liver Cirrhosis Therapeutics Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Liver Cirrhosis Therapeutics Sales by Regions 2015-2020 (K Units)
Table 9. Global Liver Cirrhosis Therapeutics Sales Market Share by Regions (2015-2020)
Table 10. Global Liver Cirrhosis Therapeutics Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Liver Cirrhosis Therapeutics Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Liver Cirrhosis Therapeutics Sales Share by Manufacturers (2015-2020)
Table 13. Global Liver Cirrhosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Liver Cirrhosis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Cirrhosis Therapeutics as of 2019)
Table 15. Liver Cirrhosis Therapeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Liver Cirrhosis Therapeutics Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Liver Cirrhosis Therapeutics Price (2015-2020) (USD/Unit)
Table 18. Liver Cirrhosis Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Liver Cirrhosis Therapeutics Product Type
Table 20. Date of International Manufacturers Enter into Liver Cirrhosis Therapeutics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Liver Cirrhosis Therapeutics Sales by Type (2015-2020) (K Units)
Table 23. Global Liver Cirrhosis Therapeutics Sales Share by Type (2015-2020)
Table 24. Global Liver Cirrhosis Therapeutics Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Liver Cirrhosis Therapeutics Revenue Share by Type (2015-2020)
Table 26. Liver Cirrhosis Therapeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Liver Cirrhosis Therapeutics Sales by Application (2015-2020) (K Units)
Table 28. Global Liver Cirrhosis Therapeutics Sales Share by Application (2015-2020)
Table 29. North America Liver Cirrhosis Therapeutics Sales by Country (2015-2020) (K Units)
Table 30. North America Liver Cirrhosis Therapeutics Sales Market Share by Country (2015-2020)
Table 31. North America Liver Cirrhosis Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Liver Cirrhosis Therapeutics Revenue Market Share by Country (2015-2020)
Table 33. North America Liver Cirrhosis Therapeutics Sales by Type (2015-2020) (K Units)
Table 34. North America Liver Cirrhosis Therapeutics Sales Market Share by Type (2015-2020)
Table 35. North America Liver Cirrhosis Therapeutics Sales by Application (2015-2020) (K Units)
Table 36. North America Liver Cirrhosis Therapeutics Sales Market Share by Application (2015-2020)
Table 37. Europe Liver Cirrhosis Therapeutics Sales by Country (2015-2020) (K Units)
Table 38. Europe Liver Cirrhosis Therapeutics Sales Market Share by Country (2015-2020)
Table 39. Europe Liver Cirrhosis Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Liver Cirrhosis Therapeutics Revenue Market Share by Country (2015-2020)
Table 41. Europe Liver Cirrhosis Therapeutics Sales by Type (2015-2020) (K Units)
Table 42. Europe Liver Cirrhosis Therapeutics Sales Market Share by Type (2015-2020)
Table 43. Europe Liver Cirrhosis Therapeutics Sales by Application (2015-2020) (K Units)
Table 44. Europe Liver Cirrhosis Therapeutics Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Liver Cirrhosis Therapeutics Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Liver Cirrhosis Therapeutics Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Liver Cirrhosis Therapeutics Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Application (2015-2020)
Table 53. Latin America Liver Cirrhosis Therapeutics Sales by Country (2015-2020) (K Units)
Table 54. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Liver Cirrhosis Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Liver Cirrhosis Therapeutics Revenue Market Share by Country (2015-2020)
Table 57. Latin America Liver Cirrhosis Therapeutics Sales by Type (2015-2020) (K Units)
Table 58. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Type (2015-2020)
Table 59. Latin America Liver Cirrhosis Therapeutics Sales by Application (2015-2020) (K Units)
Table 60. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Application (2015-2020)
Table 69. Gilead Sciences Corporation Information
Table 70. Gilead Sciences Description and Major Businesses
Table 71. Gilead Sciences Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Gilead Sciences Product
Table 73. Gilead Sciences Recent Development
Table 74. GlaxoSmithKline Corporation Information
Table 75. GlaxoSmithKline Description and Major Businesses
Table 76. GlaxoSmithKline Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. GlaxoSmithKline Product
Table 78. GlaxoSmithKline Recent Development
Table 79. Johnson and Johnson Corporation Information
Table 80. Johnson and Johnson Description and Major Businesses
Table 81. Johnson and Johnson Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Johnson and Johnson Product
Table 83. Johnson and Johnson Recent Development
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Merck Product
Table 88. Merck Recent Development
Table 89. Roche Corporation Information
Table 90. Roche Description and Major Businesses
Table 91. Roche Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Roche Product
Table 93. Roche Recent Development
Table 94. Bristol-Myers Squibb Corporation Information
Table 95. Bristol-Myers Squibb Description and Major Businesses
Table 96. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Bristol-Myers Squibb Product
Table 98. Bristol-Myers Squibb Recent Development
Table 99. Conatus Pharmaceuticals Corporation Information
Table 100. Conatus Pharmaceuticals Description and Major Businesses
Table 101. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Conatus Pharmaceuticals Product
Table 103. Conatus Pharmaceuticals Recent Development
Table 104. Gwo Xi Stem Cell Applied Technology Corporation Information
Table 105. Gwo Xi Stem Cell Applied Technology Description and Major Businesses
Table 106. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Gwo Xi Stem Cell Applied Technology Product
Table 108. Gwo Xi Stem Cell Applied Technology Recent Development
Table 109. Instituto Grifols Corporation Information
Table 110. Instituto Grifols Description and Major Businesses
Table 111. Instituto Grifols Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Instituto Grifols Product
Table 113. Instituto Grifols Recent Development
Table 114. Intercept Pharmaceuticals Corporation Information
Table 115. Intercept Pharmaceuticals Description and Major Businesses
Table 116. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Intercept Pharmaceuticals Product
Table 118. Intercept Pharmaceuticals Recent Development
Table 119. NGM Biopharmaceuticals Corporation Information
Table 120. NGM Biopharmaceuticals Description and Major Businesses
Table 121. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. NGM Biopharmaceuticals Product
Table 123. NGM Biopharmaceuticals Recent Development
Table 124. Norgine Corporation Information
Table 125. Norgine Description and Major Businesses
Table 126. Norgine Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Norgine Product
Table 128. Norgine Recent Development
Table 129. Pharmicell Corporation Information
Table 130. Pharmicell Description and Major Businesses
Table 131. Pharmicell Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Pharmicell Product
Table 133. Pharmicell Recent Development
Table 134. Salix Pharmaceuticals Corporation Information
Table 135. Salix Pharmaceuticals Description and Major Businesses
Table 136. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Salix Pharmaceuticals Product
Table 138. Salix Pharmaceuticals Recent Development
Table 139. Stempeutics Research Corporation Information
Table 140. Stempeutics Research Description and Major Businesses
Table 141. Stempeutics Research Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Stempeutics Research Product
Table 143. Stempeutics Research Recent Development
Table 144. Global Liver Cirrhosis Therapeutics Sales Forecast by Regions (2021-2026) (K Units)
Table 145. Global Liver Cirrhosis Therapeutics Sales Market Share Forecast by Regions (2021-2026)
Table 146. Global Liver Cirrhosis Therapeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 147. Global Liver Cirrhosis Therapeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 148. North America: Liver Cirrhosis Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 149. North America: Liver Cirrhosis Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Europe: Liver Cirrhosis Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 151. Europe: Liver Cirrhosis Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 152. Asia Pacific: Liver Cirrhosis Therapeutics Sales Forecast by Region (2021-2026) (K Units)
Table 153. Asia Pacific: Liver Cirrhosis Therapeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Latin America: Liver Cirrhosis Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 155. Latin America: Liver Cirrhosis Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Middle East and Africa: Liver Cirrhosis Therapeutics Sales Forecast by Country (2021-2026) (K Units)
Table 157. Middle East and Africa: Liver Cirrhosis Therapeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 159. Key Challenges
Table 160. Market Risks
Table 161. Main Points Interviewed from Key Liver Cirrhosis Therapeutics Players
Table 162. Liver Cirrhosis Therapeutics Customers List
Table 163. Liver Cirrhosis Therapeutics Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Liver Cirrhosis Therapeutics Product Picture
Figure 2. Global Liver Cirrhosis Therapeutics Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Liver Cirrhosis Therapeutics Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Liver Cirrhosis Therapeutics Report Years Considered
Figure 10. Global Liver Cirrhosis Therapeutics Market Size 2015-2026 (US$ Million)
Figure 11. Global Liver Cirrhosis Therapeutics Sales 2015-2026 (K Units)
Figure 12. Global Liver Cirrhosis Therapeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2015-2020)
Figure 14. Global Liver Cirrhosis Therapeutics Sales Market Share by Region in 2019
Figure 15. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2015-2020)
Figure 16. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region in 2019
Figure 17. Global Liver Cirrhosis Therapeutics Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Liver Cirrhosis Therapeutics Revenue in 2019
Figure 19. Liver Cirrhosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2015-2020)
Figure 21. Global Liver Cirrhosis Therapeutics Sales Market Share by Type in 2019
Figure 22. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2015-2020)
Figure 23. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type in 2019
Figure 24. Global Liver Cirrhosis Therapeutics Market Share by Price Range (2015-2020)
Figure 25. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2015-2020)
Figure 26. Global Liver Cirrhosis Therapeutics Sales Market Share by Application in 2019
Figure 27. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2015-2020)
Figure 28. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application in 2019
Figure 29. North America Liver Cirrhosis Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Liver Cirrhosis Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Liver Cirrhosis Therapeutics Sales Market Share by Country in 2019
Figure 32. North America Liver Cirrhosis Therapeutics Revenue Market Share by Country in 2019
Figure 33. U.S. Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Liver Cirrhosis Therapeutics Market Share by Type in 2019
Figure 38. North America Liver Cirrhosis Therapeutics Market Share by Application in 2019
Figure 39. Europe Liver Cirrhosis Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Liver Cirrhosis Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Liver Cirrhosis Therapeutics Sales Market Share by Country in 2019
Figure 42. Europe Liver Cirrhosis Therapeutics Revenue Market Share by Country in 2019
Figure 43. Germany Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Liver Cirrhosis Therapeutics Market Share by Type in 2019
Figure 54. Europe Liver Cirrhosis Therapeutics Market Share by Application in 2019
Figure 55. Asia Pacific Liver Cirrhosis Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Liver Cirrhosis Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Region in 2019
Figure 58. Asia Pacific Liver Cirrhosis Therapeutics Revenue Market Share by Region in 2019
Figure 59. China Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Liver Cirrhosis Therapeutics Market Share by Type in 2019
Figure 82. Asia Pacific Liver Cirrhosis Therapeutics Market Share by Application in 2019
Figure 83. Latin America Liver Cirrhosis Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Liver Cirrhosis Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Country in 2019
Figure 86. Latin America Liver Cirrhosis Therapeutics Revenue Market Share by Country in 2019
Figure 87. Mexico Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Liver Cirrhosis Therapeutics Market Share by Type in 2019
Figure 94. Latin America Liver Cirrhosis Therapeutics Market Share by Application in 2019
Figure 95. Middle East and Africa Liver Cirrhosis Therapeutics Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Market Share by Country in 2019
Figure 99. Turkey Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Liver Cirrhosis Therapeutics Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Liver Cirrhosis Therapeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Liver Cirrhosis Therapeutics Market Share by Type in 2019
Figure 106. Middle East and Africa Liver Cirrhosis Therapeutics Market Share by Application in 2019
Figure 107. North America Liver Cirrhosis Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Liver Cirrhosis Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Liver Cirrhosis Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Liver Cirrhosis Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Liver Cirrhosis Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Liver Cirrhosis Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Liver Cirrhosis Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Liver Cirrhosis Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Liver Cirrhosis Therapeutics Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
肝硬変の世界市場（～2026年） Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse. Alcohol has been identified as the strongest risk factor for liver cirrhosis. Market Analysis and Insights: Global Liver Cirrhosis Market The global Liver Cirrhosis …- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …
- 原発性胆汁性肝硬変薬の世界市場（～2026年） Market Analysis and Insights: Global Primary Biliary Cirrhosis Drug Market The global Primary Biliary Cirrhosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Primary Biliary Cirrhosis Drug Scope and Market Size …
- 慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 肝性脳症（HE）治療薬の世界市場（～2026年） HE is a potentially fatal brain disorder that is caused by liver damage, which results in the failure to remove toxins from the blood. The availability of patient-focused programs to assist disease management is one of the primary growth drivers for the global hepatic encephalopathy (HE) therapeutic…